Home

Lundbeck sites Contact Us

  • Switch to Serdolect
  • Prescribing Serdolect
  • Supportive Material
  • Publications
  • About Schizophrenia
You are here: Home » Publications » Excellent patient acceptability » EPS at placebo level

EPS at placebo level

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

Zimbroff et al. Am J Psychiatry 1997;154:782-91.

Sertindole is associated with a low level of extrapyramidal symptoms in schizophrenic patients: Results of a phase III trial

Hale et al. Int J Psych Pract 2000; 4: 47-54.

Published: 07/02/2007   Last updated: 18/05/2010
Print  
  • Publications
    • Efficacy
      • At least as effective as risperidone
      • As effective as haloperidol
      • Maintaining long-term efficacy
    • Excellent patient acceptability
      • Effective without sedation
      • EPS at placebo level
      • Weight-gain
    • Enables patients to function
      • Improvement in cognitive function
      • Maintaining sexual function
    • Excellent patient safety
      • Low all cause mortality
    • Other publications

Literature Search


 
  • Switch to Serdolect
  • Prescribing Serdolect
  • Supportive Material
  • Publications
  • About Schizophrenia

www.irecover.com www.cipralex.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us

Lundbeck logo